JP2008516985A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516985A5
JP2008516985A5 JP2007537014A JP2007537014A JP2008516985A5 JP 2008516985 A5 JP2008516985 A5 JP 2008516985A5 JP 2007537014 A JP2007537014 A JP 2007537014A JP 2007537014 A JP2007537014 A JP 2007537014A JP 2008516985 A5 JP2008516985 A5 JP 2008516985A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antibody
zcytor21
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007537014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008516985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/037332 external-priority patent/WO2006044840A2/en
Publication of JP2008516985A publication Critical patent/JP2008516985A/ja
Publication of JP2008516985A5 publication Critical patent/JP2008516985A5/ja
Pending legal-status Critical Current

Links

JP2007537014A 2004-10-18 2005-10-18 可溶性ｚｃｙｔｏｒ２１、抗ｚｃｙｔｏｒ２１抗体及び結合パートナー、並びに炎症における使用方法 Pending JP2008516985A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61965104P 2004-10-18 2004-10-18
US62220704P 2004-10-25 2004-10-25
PCT/US2005/037332 WO2006044840A2 (en) 2004-10-18 2005-10-18 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation

Publications (2)

Publication Number Publication Date
JP2008516985A JP2008516985A (ja) 2008-05-22
JP2008516985A5 true JP2008516985A5 (enExample) 2008-12-11

Family

ID=36090952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007537014A Pending JP2008516985A (ja) 2004-10-18 2005-10-18 可溶性ｚｃｙｔｏｒ２１、抗ｚｃｙｔｏｒ２１抗体及び結合パートナー、並びに炎症における使用方法

Country Status (12)

Country Link
US (3) US20060142192A1 (enExample)
EP (1) EP1802657A2 (enExample)
JP (1) JP2008516985A (enExample)
KR (1) KR20070084330A (enExample)
AU (1) AU2005295421A1 (enExample)
BR (1) BRPI0516603A (enExample)
CA (1) CA2584078A1 (enExample)
EA (1) EA200700823A1 (enExample)
IL (1) IL182186A0 (enExample)
MX (1) MX2007004597A (enExample)
NO (1) NO20072514L (enExample)
WO (1) WO2006044840A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197306A1 (en) * 2000-05-24 2004-10-07 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
MX2007004597A (es) * 2004-10-18 2007-06-22 Zymogenetics Inc Zcytor21 soluble, anticuerpos anti-zcytor21 y moleculas de enlace y metodos de uso en inflamacion.
CA2624763A1 (en) * 2005-10-18 2007-04-26 Zymogenetics, Inc. Il-17c antagonists and methods of using the same
CA2666842A1 (en) * 2006-10-18 2008-04-24 Zymogenetics, Inc. Il-17c antagonists and methods of using the same
SG11201401202YA (en) * 2011-10-19 2014-06-27 Morphosys Ag Antagonists of il17c for the treatment of inflammatory disorders
JP2018529704A (ja) * 2015-10-05 2018-10-11 モルフォシス・アーゲー アトピー性皮膚炎の治療および／または予防のためのｉｌ−１７ｃの拮抗剤
SG11201806161TA (en) 2016-02-19 2018-08-30 Morphosys Ag Antibodies for il-17c
AU2022291273A1 (en) * 2021-06-10 2024-01-25 Janssen Biotech, Inc. Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707021A (es) * 1995-03-23 1997-11-29 Immunex Corp Receptor de il-7.
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20020177188A1 (en) * 1998-05-15 2002-11-28 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) * 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US20040197306A1 (en) * 2000-05-24 2004-10-07 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
CN1444652A (zh) * 2000-05-24 2003-09-24 先灵公司 哺乳动物受体蛋白;相关试剂和方法
US20030096969A1 (en) * 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2005508615A (ja) * 2001-07-09 2005-04-07 ザイモジェネティクス，インコーポレイティド ヒトサイトカイン受容体
MX2007004597A (es) * 2004-10-18 2007-06-22 Zymogenetics Inc Zcytor21 soluble, anticuerpos anti-zcytor21 y moleculas de enlace y metodos de uso en inflamacion.
CA2624763A1 (en) * 2005-10-18 2007-04-26 Zymogenetics, Inc. Il-17c antagonists and methods of using the same

Similar Documents

Publication Publication Date Title
Müller et al. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
CN105968204B (zh) 一种抗前列腺特异性膜抗原的单域重链抗体
AU2012205384B2 (en) IL-27 antagonists for treating inflammatory diseases
JP2009197002A5 (enExample)
JP2022046510A (ja) 血清アルブミン結合フィブロネクチンｉｉｉ型ドメイン
EA201370105A1 (ru) Человеческие антитела против человеческого tnf-подобного лиганда-1а (tl1a)
JP2019510739A5 (enExample)
JP2010517529A5 (enExample)
JP2012012402A5 (enExample)
JP2002542157A5 (enExample)
CN105968201A (zh) 针对前列腺特异性膜抗原的单域重链抗体
CN106414498A (zh) TNF α的结合成员
JP2008517922A5 (enExample)
JP2002537362A (ja) ビオチン化ケモカイン抗体複合体
JP2016509585A5 (enExample)
JP2014500862A5 (enExample)
JP2005505256A5 (enExample)
JP2004534513A5 (enExample)
JP2005528884A5 (enExample)
JP2005535562A5 (enExample)
Golikova et al. Levels of TNF, TNF autoantibodies and soluble TNF receptors in patients with bronchial asthma
JP2010521139A5 (enExample)
CN111094354A (zh) 凝血酶抗体、其抗原结合片段及医药用途
CN105524170A (zh) 能特异结合前列腺特异性膜抗原的纳米抗体
Sthoeger et al. The beneficial effects of Xolair®(omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)-The Israeli arm of the INNOVATE study